CALC — Calcimedica Cashflow Statement
0.000.00%
Last trade - 00:00- $24.45m
- $5.78m
Annual cashflow statement for Calcimedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.5 | -35.8 | -35.6 | -34.4 | -13.7 |
| Depreciation | |||||
| Non-Cash Items | -0.369 | 5.43 | 10.6 | 8.84 | -7.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.56 | -1.63 | 1.83 | -0.267 | -0.495 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -32.1 | -31.5 | -22.9 | -25.7 | -21.1 |
| Capital Expenditures | -1.02 | -0.488 | -0.308 | -0.078 | -0.008 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -41.5 | 11.2 | 27.3 | 8.96 | -4.42 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -42.6 | 10.8 | 27 | 8.88 | -4.42 |
| Financing Cash Flow Items | -4.16 | 0 | -0.139 | 10.3 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 92.2 | 0.695 | -0.139 | 20.9 | 28 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.5 | -20.1 | 3.94 | 4.05 | 2.4 |